Señales en vivo de SEER | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	232 183
Volumen promedio	528 593
Capitalización de mercado	145.09M
EPS	$0 ( 2024-02-29 )
Próxima fecha de ganancias	( $-0.310 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.660
ATR14	$0.00300 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-07	Farokhzad Omid	Sell	52 857	Class A Common Stock
2024-02-06	Kogan Elona	Buy	123 153	Class A Common Stock
2024-02-22	Kogan Elona	Sell	12 684	Class A Common Stock
2024-02-06	Kogan Elona	Buy	140 000	Employee Stock Option (right to buy)
2024-02-06	Kogan Elona	Buy	79 729	Employee Stock Option (right to buy)

INSIDER POWER
86.12
Last 98 transactions
Buy: 6 813 760 \| Sell: 922 350

Volumen Correlación

Largo: 0.29 (neutral)

Corto: 0.91 (very strong)

Signal:(68.252) Expect same movement, but be aware

Seer, Inc. Correlación

10 Correlaciones Más Positivas
GXGX	0.92
CRON	0.911
NVTSW	0.908
IRBT	0.908
EVLO	0.906
CREG	0.903
SWAV	0.902
EPSN	0.899
HOL	0.898
BCAB	0.897

10 Correlaciones Más Negativas
BRIV	-0.911
PATK	-0.908
ALXN	-0.907
APMI	-0.906
GMFI	-0.905
ENTF	-0.905
CBRG	-0.904
ACAB	-0.903
ENER	-0.903
EMLD	-0.903

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Seer, Inc. Correlación - Moneda/Commodity

-0.69
( moderate negative )

-0.71
( moderate negative )

0.00
( neutral )

-0.58
( weak negative )

0.50
( neutral )

Seer, Inc. Finanzas

Annual	2023
Ingresos:	$15.18M
Beneficio Bruto:	$1.45M (9.54 %)
EPS:	$-1.350

FY	2023
Ingresos:	$15.18M
Beneficio Bruto:	$1.45M (9.54 %)
EPS:	$-1.350

FY	2022
Ingresos:	$14.69M
Beneficio Bruto:	$6.74M (45.91 %)
EPS:	$-1.420

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.164

Financial Reports:

No articles found.

Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Actualizaciones en tiempo real para Seer, Inc. [SEER]

Upcoming Earnings Alert